Suppr超能文献

精神分裂症的社会心理功能:某些症状或人口统计学特征是否是各功能领域的预测因素?

Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?

作者信息

Suttajit Sirijit, Arunpongpaisal Suwanna, Srisurapanont Manit, Thavichachart Nuntika, Kongsakon Ronnachai, Chantakarn Sunanta, Chantarasak Vasu, Jariyavilas Apichat, Jaroensook Piyadit, Kittiwattanagul Khanogwan, Nerapusee Osot

机构信息

Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Department of Psychiatry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Neuropsychiatr Dis Treat. 2015 Sep 29;11:2471-7. doi: 10.2147/NDT.S88085. eCollection 2015.

Abstract

This study aimed to examine symptoms/demographic characteristics as predictors for psychosocial functioning among individuals with schizophrenia. The Personal and Social Performance (PSP) scale was used to assess psychosocial functioning. Other measures of interest included were the Clinical Global Impression, Severity scale, and the Marder's five-factor model of the Positive and Negative Syndrome Scale. This study included 199 participants with non-acute stage schizophrenia. Spearman correlation coefficients and stepwise multiple linear regression analyses were applied to determine the correlates and predictors of PSP domain/total scores. Younger age, earlier age of schizophrenia onset, severe illness, positive symptoms, negative symptoms, disorganized thought, hostility/excitement, and anxiety/depression were found to significantly correlate with poor functioning. Severe illness and negative symptoms are the main predictors of greater impairment of socially useful activities, personal and social relationships, and self-care. Further prospective studies in other settings, which would include an increased number of variables such as neurocognitive function and social support, are warranted.

摘要

本研究旨在探讨症状/人口统计学特征作为精神分裂症患者心理社会功能预测指标的情况。采用个人和社会表现(PSP)量表评估心理社会功能。其他感兴趣的测量指标包括临床总体印象、严重程度量表以及阳性和阴性症状量表的马德五因素模型。本研究纳入了199名非急性期精神分裂症患者。应用斯皮尔曼相关系数和逐步多元线性回归分析来确定PSP领域/总分的相关因素和预测指标。研究发现,年龄较小、精神分裂症发病年龄较早、病情严重、阳性症状、阴性症状、思维紊乱、敌意/兴奋以及焦虑/抑郁与功能不良显著相关。病情严重和阴性症状是社会有益活动、个人和社会关系以及自我照料受损更严重的主要预测指标。有必要在其他环境中开展进一步的前瞻性研究,纳入更多变量,如神经认知功能和社会支持等。

相似文献

1
Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
Neuropsychiatr Dis Treat. 2015 Sep 29;11:2471-7. doi: 10.2147/NDT.S88085. eCollection 2015.
2
Predictors of quality of life among individuals with schizophrenia.
Neuropsychiatr Dis Treat. 2015 May 28;11:1371-9. doi: 10.2147/NDT.S81024. eCollection 2015.
3
Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.
Schizophr Res. 2008 Sep;104(1-3):287-93. doi: 10.1016/j.schres.2008.04.037. Epub 2008 Jul 1.
4
Symptom severity is more closely associated with social functioning status in inpatients with schizophrenia than cognitive deficits.
Shanghai Arch Psychiatry. 2012 Apr;24(2):83-90. doi: 10.3969/j.issn.1002-0829.2012.02.003.
6
Psychosocial functioning as a personal resource promoting a milder course of schizophrenia.
J Psychiatr Res. 2022 Apr;148:121-126. doi: 10.1016/j.jpsychires.2022.01.062. Epub 2022 Jan 29.
7
Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.
Eur Psychiatry. 2012 Aug;27(6):432-6. doi: 10.1016/j.eurpsy.2011.02.015. Epub 2011 May 23.
10

引用本文的文献

2
Lay health worker-delivered case management for early episodes of psychosis in Bangkok, Thailand (Lay-CARE): a single-centre, pragmatic, randomised controlled trial.
Lancet Reg Health Southeast Asia. 2025 Jun 10;38:100617. doi: 10.1016/j.lansea.2025.100617. eCollection 2025 Jul.
3
Predictors of Psychosocial Functioning Among Long-stay Schizophrenia Patients in a Malaysian Mental Institution.
Malays J Med Sci. 2024 Dec;31(6):178-193. doi: 10.21315/mjms2024.31.6.14. Epub 2024 Dec 31.
4
Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review.
Front Pharmacol. 2024 Jan 4;14:1321112. doi: 10.3389/fphar.2023.1321112. eCollection 2023.
8
Lurasidone Augmentation of Clozapine in Schizophrenia-Retrospective Chart Review.
Brain Sci. 2023 Mar 4;13(3):445. doi: 10.3390/brainsci13030445.
9
Cerebral, Psychosocial, Family Functioning and Disability of Persons with Schizophrenia.
Neuropsychiatr Dis Treat. 2022 Sep 15;18:2069-2082. doi: 10.2147/NDT.S370449. eCollection 2022.
10
Real-World Functioning in Psychiatric Outpatients: Predictive Factors.
J Clin Med. 2022 Jul 28;11(15):4400. doi: 10.3390/jcm11154400.

本文引用的文献

1
Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
Psychiatry Res. 2014 Aug 30;218(3):284-9. doi: 10.1016/j.psychres.2014.04.018. Epub 2014 Apr 16.
2
The psychopathological characteristics of treatment discontinuation group in 6-month treatment with paliperidone ER.
Int J Clin Pract. 2012 Oct;66(10):969-75. doi: 10.1111/j.1742-1241.2012.03016.x.
3
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.
Psychiatry Res. 2012 May 15;197(1-2):1-6. doi: 10.1016/j.psychres.2012.02.013. Epub 2012 Mar 18.
4
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.
Schizophr Res. 2012 May;137(1-3):147-50. doi: 10.1016/j.schres.2012.01.015. Epub 2012 Feb 6.
5
Cognitive and symptomatic predictors of functional disability in schizophrenia.
Schizophr Res. 2011 Mar;126(1-3):257-64. doi: 10.1016/j.schres.2010.08.007. Epub 2010 Sep 15.
6
Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.
BMC Psychiatry. 2010 Aug 18;10:63. doi: 10.1186/1471-244X-10-63.
7
Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.
Am J Psychiatry. 2010 Sep;167(9):1116-24. doi: 10.1176/appi.ajp.2010.09101406. Epub 2010 May 17.
8
Impairment, disability, social support and depression among older parents in rural Thailand.
Psychol Med. 2010 Oct;40(10):1711-21. doi: 10.1017/S003329170999208X. Epub 2010 Jan 8.
9
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
Int J Neuropsychopharmacol. 2010 May;13(4):451-60. doi: 10.1017/S1461145709990939. Epub 2009 Nov 4.
10
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.
Schizophr Res. 2009 Sep;113(2-3):189-99. doi: 10.1016/j.schres.2009.03.035. Epub 2009 Jul 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验